Skip to main navigation Skip to search Skip to main content

Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4) : a double-blind, multicentre, phase 3, randomised, placebo-controlled trial

  • F Saad
  • , Karim Fizazi
  • , Viorel Jinga
  • , Eleni Efstathiou
  • , Peter Fong
  • , Lowell Hart
  • , T Marttila
  • , Robert Jones
  • , Raymond McDermott
  • , Manf Wirth
  • , David MacLean
  • , Kazuhiro Suzuki
  • , Wang Ling
  • , Hideyuki Akaza
  • , Joel Nelson
  • , Howard I Scher
  • , Robert Dreicer
  • , Iain Webb
  • , Ronald de Wit
  • , Teuvo Tammela

    Research output: Contribution to journal › Article › Scientific › peer-review

    116 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)338-348
    JournalThe Lancet Oncology
    Volume16
    Issue number3
    DOIs
    Publication statusPublished - 2015
    Publication typeA1 Journal article-refereed

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Publication forum classification

    • Publication forum level 2

    Cite this